Organigram (TSE:OGI) Reaches New 52-Week Low – Should You Sell?

Organigram Holdings Inc. (TSE:OGIGet Free Report) shares hit a new 52-week low during trading on Monday . The stock traded as low as C$1.39 and last traded at C$1.43, with a volume of 109013 shares changing hands. The stock had previously closed at C$1.45.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on OGI shares. Canaccord Genuity Group reduced their target price on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating for the company in a research note on Monday, December 9th. ATB Capital reduced their price objective on shares of Organigram from C$5.25 to C$3.50 in a research report on Tuesday, December 17th.

View Our Latest Analysis on Organigram

Organigram Trading Down 2.7 %

The company has a debt-to-equity ratio of 3.07, a quick ratio of 2.62 and a current ratio of 3.36. The company has a 50 day simple moving average of C$1.80 and a 200 day simple moving average of C$2.12. The company has a market capitalization of C$177.90 million, a PE ratio of -3.04, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13.

About Organigram

(Get Free Report)

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

Read More

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.